Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies
暂无分享,去创建一个
Georgia D. Koutsouri | Maria Braoudaki | Dimitrios Dionisios Koutsouris | Ioannis N. Kouris | Anna Paidi | George I. Lambrou | G. Lambrou | M. Braoudaki | D. Koutsouris | A. Paidi | G. Koutsouri
[1] C. Maurer-Morelli,et al. Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma , 2013, Frontiers in Oncology.
[2] A. Baruzzi,et al. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III , 2014, Molecular oncology.
[3] T. Jiang,et al. Identifying Ki-67 specific miRNA–mRNA interactions in malignant astrocytomas , 2013, Neuroscience Letters.
[4] F. Tzortzatou-Stathopoulou,et al. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms , 2014, Journal of Hematology & Oncology.
[5] George I. Lambrou,et al. Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach , 2011, Journal of Clinical Bioinformatics.
[6] H. Fuchs,et al. MiR‐34a deficiency accelerates medulloblastoma formation in vivo , 2015, International journal of cancer.
[7] P. Northcott,et al. Normal and oncogenic roles for microRNAs in the developing brain , 2009, Cell cycle.
[8] Aliasgar Moiyadi,et al. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. , 2010, Journal of cancer research and therapeutics.
[9] Michael D. Taylor,et al. MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma* , 2012, The Journal of Biological Chemistry.
[10] Satoshi O. Suzuki,et al. MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance , 2010, Clinical Cancer Research.
[11] K. Cooney,et al. Intracranial germ cell tumors. , 2000, The oncologist.
[12] B. Alisjahbana,et al. Virological failure and drug resistance during first line anti‐retroviral treatment in Indonesia , 2013, Journal of medical virology.
[13] Giuseppe Basso,et al. MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma , 2011, PloS one.
[14] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[15] V. Sée,et al. Mir-34a Mimics Are Potential Therapeutic Agents for p53-Mutated and Chemo-Resistant Brain Tumour Cells , 2014, PloS one.
[16] Jian Zheng,et al. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186 , 2015, Oncotarget.
[17] Chiang-Ching Huang,et al. MicroRNA expression profiling for Molecular Classification of pediatric brain tumors , 2011, Pediatric blood & cancer.
[18] Michael H Handler,et al. Survey of MicroRNA expression in pediatric brain tumors , 2011, Pediatric blood & cancer.
[19] D. Figarella-Branger,et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] H. Ohgaki,et al. Genetic Alterations in MicroRNAs in Medulloblastomas , 2012, Brain pathology.
[21] A. Farcomeni,et al. MicroRNA profiling in human medulloblastoma , 2009, International journal of cancer.